Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Nov 3, 2023 · 10-Q · 34 days after period end · 0001213900-23-083013
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$9.86M | -$7.69M | -$10.78M | -$7.97M |
| EPS Diluted | -$0.87 | -$0.68 | -$0.96 | -$1.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 3, 2023 · 34 d after period end
